Evidence map›Paper›PMID 32793204›Full record

ArticleFrontiers in immunology2020

CD4

Ninoshka R J Fernandes, Nicholas S Reilly, Dillon C Schrock, Denise C Hocking, Patrick W Oakes, Deborah J Fowell

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ninoshka R J FernandesDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, United States.
Nicholas S ReillyDepartment of Physics and Astronomy, University of Rochester, Rochester, NY, United States.
Dillon C SchrockDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, United States.
Denise C HockingDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, United States.
Patrick W OakesDepartment of Physics and Astronomy, University of Rochester, Rochester, NY, United States.
Deborah J FowellDavid H. Smith Center for Vaccine Biology and Immunology, Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY, United States.
University of Rochester Medical Center · USUniversity of Rochester · US

Funding

Target T Cell Modulation by CD4+CD25+ Regulatory T CellsR01AI070826 · NIAID · UNIVERSITY OF ROCHESTER · PI FOWELL, DEBORAH J · 2007 to 2010
$1.5M
NIAID NIH HHS R01 AI070826
6 · The paper itself

Abstract

The extracellular matrix (ECM) is extensively remodeled during inflammation providing essential guidance cues for immune cell migration and signals for cell activation and survival. There is increasing interest in the therapeutic targeting of ECM to mitigate chronic inflammatory diseases and enhance access to the tumor microenvironment. T cells utilize the ECM as a scaffold for interstitial migration, dependent on T cell expression of matrix-binding integrins α

Indexed as

Adoptive TransferAnimalsCD4-Positive T-LymphocytesCell MovementCells, CulturedExtracellular MatrixFibronectinsInflammationIntestinal MucosaMiceMice, Inbred BALB CMice, TransgenicPeptide FragmentsPolymerizationReceptors, Antigen, T-CellSkinFibronectinsPeptide FragmentspUR4 peptideReceptors, Antigen, T-Cellextracellular matrixfibronectininflammationmigrationskinT cell

Identifiers

PMID32793204
PMCPMC7393769
OpenAlexW3036039434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.